Redalpine
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Helical raises a £7.5m seed round led by redalpine to build virtual labs for pharma research
Helical is a virtual lab platform that enables pharmaceutical scientists to test biological hypotheses computationally before running physical experiments. It provides a shared system for biologists and machine learning engineers to run, validate and reproduce discovery workflows.
9fin secures £130m Series C led by HarbourVest to build clearer view of debt markets
9fin is a data and analytics platform for debt capital markets. It provides real-time information and tools to help credit professionals analyse markets, track developments, and make decisions.
Synthesized raises £15m Series A led by Redalpine to automate the most difficult parts of testing with agentic AI
Synthesized provides agentic AI infrastructure for software testing, automating the creation of realistic, compliant test data and environments so regulated organisations can test and release software faster and more safely.
DaltonTx launches with £4m seed round from Redalpine, IQ Capital and Seedcamp to build the intelligence backbone of drug discovery
DaltonTx builds an adaptive AI platform for drug discovery that integrates directly into scientific workflows, helping research teams analyse data, design molecules and make decisions across small molecule and biologic programmes.
Magdrive raises £8m seed funding led by Redalpine for its next-generation spacecraft propulsion system
Magdrive develops high-thrust electric propulsion systems for satellites using solid metal propellants, enabling more efficient manoeuvring, longer missions and future in-space servicing and manufacturing.
9fin raises £40m Series B led by Highland Europe to build next generation of debt capital markets technology
9fin provides AI powered analytics and research tools for debt capital markets, giving professionals faster access to intelligence across leveraged loans, high yield bonds, private credit and distressed debt.
ExpressionEdits raises £10m seed round to advance protein expression using AI-driven intronisation technology
ExpressionEdits develops an AI-driven gene design platform that improves protein expression by redesigning genes with introns, helping researchers and manufacturers produce therapeutic proteins that are difficult to express using existing methods.
More venture news
- 21 May 2026
ImperagenImperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering
SeedLife Sciences - 11 May 2026
Scarlet TherapeuticsScarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases
SeedLife Sciences - 12 May 2026
White CircleWhite Circle raises £8m from leading industry angels for platform that monitors AI model behaviour
SeedAI
